AwardedSpainGoods€278,267
suministro de principios activos denominados "ELAFIBRANOR 80 MG comprimido oral;CABOZANTINIB 40 MG oral Y CABOZANTINIB 20 MG oral" para el Hospital Universitario de Gran Canaria Dr.Negrín.
- Published
- Published 18 June 2026
Overview
Hospital Universitario de Gran Canaria Dr. Negrín procured pharmaceutical active ingredients comprising Elafibranor 80 mg oral tablets, Cabozantinib 40 mg oral, and Cabozantinib 20 mg oral. The contract was awarded to IPSEN PHARMA, S.A.U. on 6 May 2026 for a value of €595,636.80.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €278,267
- Procedure
- Direct
- Published
- 18 June 2026
Various medicinal products
Award outcome
- Awarded value
- €595,637
- Award date
- 6 May 2026
- IPSEN PHARMA, S.A.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
18 June 2026
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.